Caricamento...
Novel treatments for immune thrombocytopenia
Primary immune thrombocytopenia (ITP) is caused by platelet autoantibodies and T-cell dysregulation. Both platelets and their precursor megakaryocytes may be targeted leading to platelet destruction and underproduction. Current treatments for ITP are inadequate since they do not reverse the disease...
Salvato in:
| Pubblicato in: | Presse Med |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4880474/ https://ncbi.nlm.nih.gov/pubmed/24656294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lpm.2014.02.006 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|